These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 21306418)

  • 1. Adherence to national guidelines for initiation of antiretroviral regimens in HIV patients: a Danish nationwide study.
    Petersen TS; Andersen SE; Gerstoft J; Thorsteinsson K; Larsen CS; Pedersen G; Pedersen C; Obel N
    Br J Clin Pharmacol; 2011 Jul; 72(1):116-24. PubMed ID: 21306418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perspectives on adherence and simplicity for HIV-infected patients on antiretroviral therapy: self-report of the relative importance of multiple attributes of highly active antiretroviral therapy (HAART) regimens in predicting adherence.
    Stone VE; Jordan J; Tolson J; Miller R; Pilon T
    J Acquir Immune Defic Syndr; 2004 Jul; 36(3):808-16. PubMed ID: 15213564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of injecting drug use on response to highly active antiretroviral treatment in HIV-1-infected patients: a nationwide population-based cohort study.
    Larsen MV; Omland LH; Gerstoft J; Røge BT; Larsen CS; Pedersen G; Obel N; Kronborg G
    Scand J Infect Dis; 2010 Dec; 42(11-12):917-23. PubMed ID: 20840000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Compliance with national guidelines for HIV treatment and its association with mortality and treatment outcome: a study in a Spanish cohort.
    Suárez-García I; Sobrino-Vegas P; Tejada A; Viciana P; Ribas M; Iribarren J; Díaz Menéndez M; Rivero M; Arazo P; Del Amo J; Moreno S;
    HIV Med; 2014 Feb; 15(2):86-97. PubMed ID: 24007468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reasons for noncompliance with the national guidelines for initial antiretroviral therapy of HIV-infected patients in Spain, 2010-2015.
    Suárez-García I; González J; Berenguer J; García F; Portilla J; Muga R; Moreno S; Jarrín I;
    Enferm Infecc Microbiol Clin (Engl Ed); 2019 Nov; 37(9):580-587. PubMed ID: 30982676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adherence to highly active antiretroviral therapies (HAART) in HIV-infected patients: from a predictive to a dynamic approach.
    Spire B; Duran S; Souville M; Leport C; Raffi F; Moatti JP;
    Soc Sci Med; 2002 May; 54(10):1481-96. PubMed ID: 12061483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of cataract surgery in HIV-infected individuals: a Danish Nationwide Population-based cohort study.
    Rasmussen LD; Kessel L; Molander LD; Pedersen C; Gerstoft J; Kronborg G; Obel N
    Clin Infect Dis; 2011 Dec; 53(11):1156-63. PubMed ID: 21998282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disparities in antiretroviral treatment: a comparison of behaviorally HIV-infected youth and adults in the HIV Research Network.
    Agwu AL; Fleishman JA; Korthuis PT; Siberry GK; Ellen JM; Gaur AH; Rutstein R; Gebo KA;
    J Acquir Immune Defic Syndr; 2011 Sep; 58(1):100-7. PubMed ID: 21637114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of medication adherence on survival of HIV-infected adults who start highly active antiretroviral therapy when the CD4+ cell count is 0.200 to 0.350 x 10(9) cells/L.
    Wood E; Hogg RS; Yip B; Harrigan PR; O'Shaughnessy MV; Montaner JS
    Ann Intern Med; 2003 Nov; 139(10):810-6. PubMed ID: 14623618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Depression and clinical progression in HIV-infected drug users treated with highly active antiretroviral therapy.
    Bouhnik AD; Préau M; Vincent E; Carrieri MP; Gallais H; Lepeu G; Gastaut JA; Moatti JP; Spire B;
    Antivir Ther; 2005; 10(1):53-61. PubMed ID: 15751763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Initiating highly active antiretroviral therapy and continuity of HIV care: the impact of incarceration and prison release on adherence and HIV treatment outcomes.
    Palepu A; Tyndall MW; Chan K; Wood E; Montaner JS; Hogg RS
    Antivir Ther; 2004 Oct; 9(5):713-9. PubMed ID: 15535408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Late initiation of HAART among HIV-infected patients in Spain is frequent and related to a higher rate of virological failure but not to immigrant status.
    Pérez-Molina JA; Suárez-Lozano I; Del Arco A; Teira R; Bachiller P; Pedrol E; Martínez-Alfaro E; Domingo P; Mariño A; Ribera E; Antela A; de Otero J; Navarro V; González-García J;
    HIV Clin Trials; 2011; 12(1):1-8. PubMed ID: 21388936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adherence and plasma HIV RNA responses to highly active antiretroviral therapy among HIV-1 infected injection drug users.
    Wood E; Montaner JS; Yip B; Tyndall MW; Schechter MT; O'Shaughnessy MV; Hogg RS
    CMAJ; 2003 Sep; 169(7):656-61. PubMed ID: 14517122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Initial experience of a public sector antiretroviral treatment programme for HIV-infected children and their infected parents.
    Eley B; Nuttall J; Davies MA; Smith L; Cowburn C; Buys H; Hussey G
    S Afr Med J; 2004 Aug; 94(8):643-6. PubMed ID: 15352588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 'Simply forgot' is the most frequently stated reason for missed doses of HAART irrespective of degree of adherence.
    Barfod TS; Sørensen HT; Nielsen H; Rodkjaer L; Obel N
    HIV Med; 2006 Jul; 7(5):285-90. PubMed ID: 16945072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV update: emerging clinical evidence and a review of recommendations for the use of highly active antiretroviral therapy.
    Kress KD
    Am J Health Syst Pharm; 2004 Oct; 61 Suppl 3():S3-14; quiz S15-6. PubMed ID: 15503932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of pill burden on discontinuation of the initial HAART regimen in minority female patients prescribed 1 pill/day versus any other pill burden.
    Hill S; Kavookjian J; Qian J; Chung A; Vandewaa J
    AIDS Care; 2014; 26(5):595-601. PubMed ID: 24111921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The association of perceived health, clinical status, and initiation of HAART (highly active antiretroviral therapy) in adolescents.
    Schwarz DF; Henry-Reid L; Houser J; Ma Y;
    J Adolesc Health; 2001 Sep; 29(3 Suppl):115-22. PubMed ID: 11530312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies.
    ; Sterne JA; May M; Costagliola D; de Wolf F; Phillips AN; Harris R; Funk MJ; Geskus RB; Gill J; Dabis F; Miró JM; Justice AC; Ledergerber B; Fätkenheuer G; Hogg RS; Monforte AD; Saag M; Smith C; Staszewski S; Egger M; Cole SR
    Lancet; 2009 Apr; 373(9672):1352-63. PubMed ID: 19361855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.